Rare disease patients around the world are building powerful communities and research networks. Our goal is to elevate and strengthen these communities and connect them with one another.
Rare As One Project
Rare disease is anything but rare. As many as 7,000 rare diseases affect 300 million people globally. The vast majority are not well understood, and less than 5 percent have approved treatments. Yet worldwide, patients are meeting these challenges head-on. The Rare As One project is committed to uniting these communities in their quest for cures.
Meet the Rare As One Network
We support patient-led organizations working to improve the lives of people affected by rare disease. Learn more about our grantees below.
INADcure FoundationInfantile Neuroaxonal Dystrophy
INADcure Foundation’s mission is to fund research that will lead to treatments and a cure for diseases caused by the impaired PLA2G6 gene.
APBD Research FoundationAdult Polyglucosan Body Disease
APBD Research Foundation is dedicated to increasing public awareness and understanding of Adult Polyglucosan Body Disease and supporting research studies that may lead to new treatment options and a cure.
The Yaya Foundation4H Leukodystrophy
The Yaya Foundation for 4H Leukodystrophy fights for children with 4H Leukodystrophy by building an ecosystem of patients, families, researchers, clinicians, scientific experts, and supporters.
KAT6A FoundationKAT6A Syndrome
The KAT6A Foundation supports the international KAT6A syndrome community.
CureGRIN FoundationGRIN Disorders
CureGRIN is a parent-led foundation committed to improving the lives of people living with GRIN disorders.
The EHE FoundationEpithelioid Hemangioendothelioma
The EHE Foundation’s goal is to connect its community to the latest research, treatment models, and events surrounding epithelioid hemangioendothelioma.
Our Strategic Partners
We’re proud to work alongside a number of distinguished organizations that share our goal of finding treatments and cures for rare diseases.
Patient communities are the agents and architects of their own change. We aim to lift up rare disease communities, providing them with resources and tools to be more effective advocates for—and partners in—research.
Patient communities are the agents and architects of their own change. We aim to lift up rare disease communities, providing them with resources and tools to be more effective advocates for, and partners in, research.
Collaboration is key to accelerating progress against disease. That’s why we’re working to bridge learnings within and across diseases—and among patients, researchers, clinicians, and other key community members.
Learn more about funding opportunities.
Hear Rare Disease Stories
Listen to The Story Collider podcast featuring stories about patients who are driving progress against rare disease.